6h
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
The company behind Claude forged an alliance to put its AI tools in the hands of students at hundreds of community and state colleges.
Anthropic researcher Nicholas Carlini published a blog post describing how he set 16 instances of the company’s Claude Opus 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results